Anagnostou 2012 - Intranasal Oxytocin Versus Placebo in Adults With Autism Spectrum Disorder

Molecular Autism·December 1, 2012

Evdokia Anagnostou

Summary

Pilot trial assessing safety and potential therapeutic effects of intranasal oxytocin in adults with autism spectrum disorder.

Study Details

Study Design

Randomized, double-blind, placebo-controlled crossover pilot trial

Indication

Autism spectrum disorder in adults

Intervention

Intranasal oxytocin vs placebo

Species

Human

Sample Size

19 subjects

Risk of Bias Assessment

Small pilot trial